Medkart Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.20 M
as on 10-12-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 19.20%
(FY 2022)
- Profit -273.62%
(FY 2022)
- Ebitda -434.66%
(FY 2022)
- Net Worth -74.00%
(FY 2022)
- Total Assets 118.35%
(FY 2022)
About Medkart Pharmacy
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ankur Agarwal, Parthiv Shah, and Parasharan Chari serve as directors at the Company.
- CIN/LLPIN
U74999GJ2019PTC107176
- Company No.
107176
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2019
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medkart Pharmacy Private Limited offer?
Medkart Pharmacy Private Limited offers a wide range of products and services, including Photography Services, Wedding Photographers.
Who are the key members and board of directors at Medkart Pharmacy?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankur Agarwal  | Director | 22-Mar-2019 | Current |
| Parthiv Shah | Director | 22-Mar-2019 | Current |
| Parasharan Chari | Director | 11-Apr-2019 | Current |
Financial Performance of Medkart Pharmacy.
Medkart Pharmacy Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.2% increase. The company also saw a substantial fall in profitability, with a 273.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medkart Pharmacy?
In 2022, Medkart Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Trakdem Solutions Private LimitedActive 3 years 7 months
Ankur Agarwal and Parasharan Chari are mutual person
- Emeritus Pharma Private LimitedActive 6 years 11 months
Ankur Agarwal and Parasharan Chari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medkart Pharmacy?
Medkart Pharmacy has a workforce of 105 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medkart Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medkart Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
